For details on the Caidya Transition Blueprint, or insights into our rescue study success, contact us
When your clinical trial is in distress, you don’t have time to waste. You need a partner
with experience and know how to get your studies back on track and bring them to
completion. Caidya has successfully delivered 26 rescue studies in the past five years
alone, with nearly half of those being global.

 

Equipped for Rescues

The keys to our success with rescue studies rest in the combination of preparedness
and adaptability. With a deep understanding of critical transition considerations, our
rescue experts utilize the Caidya Transition Blueprint to provide immediate structure to
the process. But a blueprint alone is not enough because no two studies are exactly
alike. We also bring our trademark adaptability to adjust as the situation requires.

 

Key Considerations

When transitioning a rescue study, we not only gain a full understanding of the specific
issues unique to that study, but we also bring knowledge of key considerations when
transitioning any rescue study, including:
  • A detailed transition plan and gap analysis
  • Open communication with the sponsor and the incumbent CRO
  • Ensure a complete knowledge transfer
  • Detailed disclosure of what needs improvement
  • CRA transition with minimal disruption
  • Transfer of regulatory submissions/obligations
  • Quality considerations – Audits (TMF, processes, etc.)

 

Blueprint for Success

With a constant eye on where we need to flex, our experts apply the Caidya Transition
Blueprint to quickly and effectively move your study from transition to independence.
Our phases include much detail, and consist of:
  • Transition kick-off
  • Knowledge acquisition
  • Transition implementation (Wave 1, 2 and 3)
  • Independence

Caidya stepped in to rescue four global trials in this rare disease rescue case study, showcasing how quick mobilization and smart site strategies drove success.


Caidya builds and locks seven databases and standards within seven months for a biotech company.



Caidya successfully integrated data from 50+ studies producing consistent dictionary, units, and visit structure for ISS/ISE reporting in a sponsor’s NDA submission.